Quantifying the federal minimal risk standard. Implications for pediatric research without a prospect of direct benefit

JAMA

Volumn 294, Issue 7, 2005, Pages 826-832

  Wendler, David ^a   Belsky, Leah ^a   Thompson, Kimberly M ^b   Emanuel, Ezekiel J ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE INJURY; CHILDHOOD MORTALITY; CLINICAL RESEARCH; GOVERNMENT REGULATION; HEALTH CARE POLICY; HUMAN RIGHTS; MEDICAL EXAMINATION; MORBIDITY; PEDIATRICS; PHYSICAL DISABILITY; PHYSICAL EXAMINATION; POPULATION RISK; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SPORT INJURY; TRAFFIC ACCIDENT; ADOLESCENT; BIOMEDICAL AND BEHAVIORAL RESEARCH; CHILD; CLINICAL TRIAL; DAILY LIFE ACTIVITY; EMPIRICAL APPROACH; ETHICS; GOVERNMENT; HUMAN; HUMAN EXPERIMENT; LEGAL APPROACH; LEGAL ASPECT; PATIENT SELECTION; POLICY; PRACTICE GUIDELINE; PROFESSIONAL STANDARD; STANDARD; STATISTICS; UNITED STATES;

BIOMEDICAL AND BEHAVIORAL RESEARCH; EMPIRICAL APPROACH; LEGAL APPROACH;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; CHILD; CLINICAL TRIALS; ETHICS COMMITTEES, RESEARCH; FEDERAL GOVERNMENT; GOVERNMENT REGULATION; GUIDELINES; HUMANS; NONTHERAPEUTIC HUMAN EXPERIMENTATION; PATIENT SELECTION; PEDIATRICS; PUBLIC POLICY; RISK ASSESSMENT; UNITED STATES;

EID: 23844498764     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.294.7.826     Document Type: Article

References (38)

1. Roberts R, Rodriquez W, Murphy D, Crescenzi T. Pediatric drug labeling: improving the safety and efficacy of pediatric therapies.JAMA. 2003;290:905-911.
2. Caldwell PHY, Murphy SB, Butow PH, Craig JC. Clinical trials in children. Lancet. 2004;364:803-811.
3. Institute of Medicine. Ethical Conduct of Clinical Research Involving Children. Washington, DC: National Academies Press; 2004.
4. Kauffman RE. Clinical trials in children. Paediatr Drugs. 2000;2:411-418.
5. Nicholson RH. Medical Research With Children: Ethics, Law, and Practice. Oxford, England: Oxford University Press; 1986.
6. Kopelman LM. When is the risk minimal enough for children to be research subjects? In: Kopelman LM, Moskop JC, eds. Children and Health Care: Moral and Social Issues. Boston, Mass: Kluwer; 1989:89-99.
7. Koocker GP, Keith-Spiegel P. Scientific issues in psychosocial and educational research with children. In: Grodin MA, Glantz LH, eds. Children as Research Subjects: Science, Ethics and Law. New York, NY: Oxford University Press; 1994:47-80.
8. Bartholome W. The ethics of non-therapeutic clinical research on children. In: Research Involving Children: Report and Recommendations. Appendix 3. Washington, DC: US Dept of Health, Education, and Welfare; 1977:3.1-3.22.
9. Ackerman TF. Moral duties of parents and nontherapeutic clinical research procedures involving children. Bioethics Q. 1980;2:94-111.
10. Ackerman TF. Nontherapeutic research procedures involving children with cancer. J Pediatr Oncol Nurs. 1994;11:134-136.
11. McCormick RA. Proxy consent in the experimental situation. Perspect Biol Med. 1974;18:2-20.
12. McCormick RA. Experimentation in children: sharing in sociality. Hastings Cent Rep. 1976;6:41-46.
13. Ramsey P. The enforcement of morals: nontherapeutic research on children: a reply to Richard McCormick. Hastings Cent Rep. 1976;6:21-30.
14. Ramsey P. Children as research subjects: a reply. Hastings Cent Rep. 1977;7:40-42.
15. 67 Federal Register 211 (2002).
16. Protection of Human Subjects, 45 CFR 46 (1991).
17. Janofsky J, Starfield B. Assessment of risk in research on children. J Pediatr. 1981;98:842-846.
18. Shah S, Whittle A, Wilfond B, Gensler G, Wendler D. How do IRBs apply the federal risk and benefit standards for pediatric research? JAMA. 2004;291:476-482.
19. McCarthy AM, Richman LC, Hoffman RP, Rubenstein L. Psychological screening of children for participation in nontherapeutic invasive research. Arch Pediatr Adolesc Med. 2001;155:1197-1203.
20. National Human Research Protections Advisory Committee. Children's Working Group Report: April 2001 Meeting. Available at: http://www.hhs.gov/ohrp/ nhrpac/mtg04-01/child-workgroup4-5-01.pdf. Accessibility verified July 11, 2005.
21. Tversky A, Kahneman D. The framing of decisions and the rationality of choice. Science. 1981;211:453-458.
22. Slovic P. Perception of risk. Science. 1987;236:280-285.
23. Weinstein N. Optimistic biases about personal risks. Science. 1989;246:1232-1233.
24. Sandman PM. Responding to Community Outrage: Strategies for Effective Risk Communication. Fairfax, Va: American Industrial Hygiene Association; 1993.
25. Tversky A, Kahneman D. Judgments under uncertainty: heuristics and biases. Science. 1974;185:1124-1131.
26. National Highway Traffic Safety Administration. Traffic Safety Facts 2003. Available at: http://www-nrd.nhtsa.dot.gov/pdf/nrd-30/NCSA/TSF2003/809774. pdf. Accessibility verified July 11, 2005.
27. National Highway Traffic Safety Administration. Traffic Safety Facts 2002. Available at: http://www-nrd.nhtsa.dot.gov/pdf/nrd-30/NCSA/TSFAnn/ TSF2002Final.pdf. Accessibility verified July 11, 2005.
28. American Sports Data. Comprehensive Study of Sports Injuries in the US. Hartsdale, NY: American Sports Data Inc; 2002.
29. Varni JW, Burwinkle TM, Seid M, Skarr D. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr. 2003;3:329-341.
30. Galena HJ. Complications occurring during diagnostic venipuncture. J Fam Pract. 1992;34:582-584.
31. Trouern-Trend JJ, Cable RG, Badon SJ, Newman GH, Popovsky MA. A case-controlled study of vasovagal reactions in blood donors. Transfusion. 1999;39:316-320.
32. Turkeltaub PC, Gergen PJ. The risk of adverse reactions from percutaneous prick-puncture allergen skin testing, venipuncture, and body measurements: data from the second National Health and Nutrition Examination Survey 1976-80 (NHANES II). J Allergy Clin Immunol. 1989;84:886-890.
33. Kopelman LM. Minimal risk as an international ethical standard in research. J Med Philos. 2004;29:351-378.
34. Resnik DB. Eliminating the daily risks standard from the definition of minimal risk. J Med Ethics. 2005;31:35-38.
35. Council for International Organizations of Medical Sciences. International Ethical Guidelines for Biomedical Research [Commentary on Guideline 13]. 2002. Available at: http://www.cioms.ch/frame_guidelines-_nov_2002.htm. Accessibility verified July 20, 2005.
36. AmericanAcademyof Pediatrics. Bright Futures Tools and Resources. Available at: http://brightfutures.aap.org/web/ healthCareProfessionalstoolsAndResources.asp. 2005. Accessibility verified July 11, 2005.
37. American Red Cross. Youth Services. Available at: http://www.redcross. org/services/youth/0,1082,0_326_,00.html. Accessibility verified July 20, 2005.
38. Habitat for Humanity. Campus Chapters and Youth Programs. Available at: http://www.habitat.org/ccyp. Accessibility verified July 11, 2005.